Francisco Ferrer

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain

Laia Domingo, María Sala, Sònia Servitja et al. · Cancer Causes & Control · 2010 · 61 citations

Breast Oncology, Cancer Risk, Cancer Epidemiology +13

Reduction in False-Positive Results after Introduction of Digital Mammography: Analysis from Four Population-based Breast Cancer Screening Programs in Spain

María Sala, Dolores Salas, Francesc Belvis et al. · Radiology · 2011 · 36 citations

Renal Transplantation With Expanded Criteria Donors: The Experience of One Portuguese Center

Francisco Ferrer, A. Mota, Rui Alves et al. · Transplantation Proceedings · 2009 · 19 citations

Portuguese Center, Expanded Criteria Donors, Urology +10

Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion

Francisco Ferrer, Marisa Roldão, Cátia Figueiredo et al. · ˜The œNephron journals/Nephron journals · 2021 · 17 citations · Full text

Immunodeficiencies, Complement Gene, Immunology +16